Skip to main content

Table 3 Kir4.1 and IL-1β immunoreactivity in patients with/without epilepsy and with/without levetiracetam use

From: Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β

IR score

With epilepsy (n = 42)

Without epilepsy (n = 31)

With levetiracetam (n = 14 )

Without levetiracetam (n = 28)

Kir4.1

4.9 ± 0.36*

6.5 ± 0.37

6.8 ± 0.62**

4.5 ± 0.37

IL-1β

5.5 ± 0.49*

1.3 ± 0.17

3.9 ± 1.14**

6.3 ± 0.46

HLA-DR

5.8 ± 0.31*

3.6 ± 0.36

4.28 ± 0.15

5.2 ± 0.40

  1. Values represent the mean immunoreactive score (IR) ± SEM. *P <0.05: significant difference compared to patients without epilepsy; **P <0.05: significant difference compared to patients without levetiracetam use.
Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094